Lidocaine Patch for Postoperative Analgesia After Laparoscopic Cholecystectomy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01485939|
Recruitment Status : Unknown
Verified December 2011 by Seoul National University Hospital.
Recruitment status was: Recruiting
First Posted : December 6, 2011
Last Update Posted : December 6, 2011
|Condition or disease||Intervention/treatment||Phase|
|Postoperative, Pain||Other: placebo patch applied Other: 5% lidocaine patch||Phase 4|
- The 5% lidocaine patch have been approved for the treatment of postherpetic neuralgia.
- The investigators hypothesized that application of a 5% lidocaine patch would be associated with reduced pain scores, pain controlled drug(opioids, NSAID) in post operative period.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Primary Purpose:||Supportive Care|
|Study Start Date :||November 2011|
|Estimated Primary Completion Date :||March 2012|
|Estimated Study Completion Date :||May 2012|
|Placebo Comparator: placebo patch||
Other: placebo patch applied
Patients in this group would applied the placebo patch after laparoscopic cholecystectomy.
|Active Comparator: lidocaine patch||
Other: 5% lidocaine patch
Patients in this group would applied the 5% lidocaine patch after laparoscopic cholecystectomy.
- post operative pain after laparoscopic cholecystectomy [ Time Frame: post operative periods ]We will measure intensity of pain(numeric rating scale)at post operative 30 minutes, 1, 2, 4, 6, 12, 24, 48 hours.
- pain controlled drug doses in postoperative periods. [ Time Frame: postoperative periods ]We will measure doses of pain controlled drug(opioid, NSAIDS) at post operative 30 minutes, 1, 2, 4, 6, 12, 24, 48 hours.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01485939
|Contact: Eunjoo Choi, MDemail@example.com|
|Korea, Republic of|
|Seoul national university Bundang hospital||Recruiting|
|Seongnam, Kyoung-ki-do, Korea, Republic of, 463-707|
|Contact: Eunjoo Choi, MD 82-31-787-6572 firstname.lastname@example.org|
|Principal Investigator: Pyung Bok Lee, MD, PhD|